Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Oramed Pharmaceuticals (ORMP) Return on Invested Capital (2017 - 2026)

Oramed Pharmaceuticals filings provide 5 years of Return on Invested Capital readings, the most recent being 0.0% for Q4 2025.

  • Quarterly Return on Invested Capital changed 0.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Invested Capital hit 0.0% in Q4 2025 for Oramed Pharmaceuticals, up from 0.0% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.0% in Q4 2025 and bottomed at 0.0% in Q3 2022.
  • Average Return on Invested Capital over 3 years is 0.0%, with a median of 0.0% recorded in 2024.
  • Peak annual rise in Return on Invested Capital hit 0bps in 2025, while the deepest fall reached 0bps in 2025.
  • Oramed Pharmaceuticals' Return on Invested Capital stood at 0.0% in 2022, then soared by 91bps to 0.0% in 2024, then skyrocketed by 381bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Return on Invested Capital are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).